Alle Fälle anzeigen
UPC APP 8392/2024
—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieSonstige prozessuale
- Parteien
- KlägerVertreter: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)BeklagteVertreter: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbH)
- Division
- Paris CD
- Richter
- Paolo Catallozzi · Presiding Judge / Judge-Rapporteur
- Technology
- Pharmaceutical & Medical
- Sprache
- —
- Erste Entscheidung
- 20. Feb. 2024
Entscheidungen
- 2024-02-20Generic application
Order of the Paris Central Division (judge-rapporteur) granting Roche Diabetes Care GmbH's application for extension of the deadline for filing its defence in a non-infringement declaration action brought by Tandem Diabetes Care (EP 2 196 231). Roche had filed a preliminary objection disputing jurisdiction which had not yet been decided; it argued it would be unreasonable to finalise a defence that might become unnecessary. The court extended the deadline to 8 April 2024, finding the extension was justified to await the preliminary objection decision, particularly given the parallel revocation action pending before the same court.
Rechtsfragen:Extension of time for filing defence pending preliminary objectionInteraction between preliminary objection proceedings and main defence deadlineParallel revocation action considerations
Dokumente
- B07D02FA56A2B9665A82CA04377664C5_en.pdf2024-02-20ENGLISH